Open Access. Powered by Scholars. Published by Universities.®
Medicinal and Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Other Pharmacy and Pharmaceutical Sciences (10)
- Medical Sciences (8)
- Life Sciences (7)
- Chemicals and Drugs (6)
- Diseases (6)
-
- Medical Specialties (4)
- Pharmaceutics and Drug Design (4)
- Biochemistry, Biophysics, and Structural Biology (3)
- Chemical and Pharmacologic Phenomena (3)
- Medical Education (3)
- Organic Chemicals (3)
- Amino Acids, Peptides, and Proteins (2)
- Bacteria (2)
- Biochemistry (2)
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Chemistry (2)
- Heterocyclic Compounds (2)
- Medical Biochemistry (2)
- Medical Pharmacology (2)
- Medicinal Chemistry and Pharmaceutics (2)
- Natural Products Chemistry and Pharmacognosy (2)
- Oncology (2)
- Organisms (2)
- Other Chemicals and Drugs (2)
- Pharmacology, Toxicology and Environmental Health (2)
- Physical Sciences and Mathematics (2)
- Translational Medical Research (2)
- Institution
-
- Chapman University (7)
- Virginia Commonwealth University (5)
- Technological University Dublin (3)
- University of Tennessee Health Science Center (3)
- Marshall University (2)
-
- Parkland College (2)
- Butler University (1)
- Harrisburg University of Science and Technology (1)
- Loma Linda University (1)
- Seton Hall University (1)
- The University of Akron (1)
- The University of Southern Mississippi (1)
- Touro College and University System (1)
- University of Connecticut (1)
- University of Kentucky (1)
- University of Louisville (1)
- University of Nebraska Medical Center (1)
- Keyword
-
- Antibiotics (2)
- Kidney (2)
- Lung cancer (2)
- NSAIDs (2)
- Nanoparticles (2)
-
- Pharmacokinetics (2)
- Pharmacy (2)
- 5-HT3 receptors (1)
- Adverse drug reactions (1)
- Allosteric modulator (1)
- Alzheimer's disease (1)
- Amixicile (1)
- Amphiphilic polymers (1)
- Anti-apoptosis protein (1)
- Anti-cancer (1)
- Anti-tumor (1)
- Anticoagulants (1)
- Antimicrobial activity (1)
- Antiproliferative; anticancer; combretastatin A-4 (1)
- Antischistosomal agents (1)
- Asymmetric reactions; Assymetric bonds; Organocatalysts (1)
- Bis imidazolium salt (1)
- Blood (1)
- Breast cancer (1)
- Breast cancer therapy (1)
- C-H activation (1)
- Carbon nanotubes (1)
- Carcinogenesis (1)
- Celecoxib (1)
- Cell cycle protein (1)
- Publication
-
- Pharmacy Faculty Articles and Research (7)
- Theses and Dissertations (5)
- Theses and Dissertations (ETD) (3)
- Doctoral (2)
- Natural Sciences Student Research Presentations (2)
-
- Articles (1)
- Biochemistry and Microbiology (1)
- Doctoral Projects (1)
- Electronic Theses and Dissertations (1)
- Harrisburg University Faculty Works (1)
- Honors Scholar Theses (1)
- Loma Linda University Electronic Theses, Dissertations & Projects (1)
- Marshall Journal of Medicine (1)
- Scholarship and Professional Work – COPHS (1)
- Seton Hall University Dissertations and Theses (ETDs) (1)
- Theses & Dissertations (1)
- Theses and Dissertations--Toxicology and Cancer Biology (1)
- Touro Yearbooks (1)
- Williams Honors College, Honors Research Projects (1)
- Publication Type
Articles 31 - 33 of 33
Full-Text Articles in Medicinal and Pharmaceutical Chemistry
Exploration Of The Srx-Prx Axis As A Small-Molecule Target, Murli Mishra
Exploration Of The Srx-Prx Axis As A Small-Molecule Target, Murli Mishra
Theses and Dissertations--Toxicology and Cancer Biology
Lung cancer is a leading cause of cancer-related mortality irrespective of gender. The Sulfiredoxin (Srx) and Peroxiredoxin (Prx) are a group of thiol-based antioxidant proteins that plays an essential role in non-small cell lung cancer. Understanding the molecular characteristics of the Srx-Prx interaction may help design the strategies for future development of therapeutic tools. Based on existing literature and preliminary data from our lab, we hypothesized that the Srx plays a critical role in lung carcinogenesis and targeting the Srx-Prx axis or Srx alone may facilitate future development of targeted therapeutics for prevention and treatment of lung cancer. First, …
Piperlongumine (Piplartine) And Analogues: Antiproliferative Microtubule-Destabilising Agents, Mary J. Meegan, Seema M. Nathwani, Brendan Twamley, Daniela M. Zisterer, Niamh O'Boyle
Piperlongumine (Piplartine) And Analogues: Antiproliferative Microtubule-Destabilising Agents, Mary J. Meegan, Seema M. Nathwani, Brendan Twamley, Daniela M. Zisterer, Niamh O'Boyle
Articles
Piperlongumine (piplartine, 1) is a small molecule alkaloid that is receiving intense interest due to its antiproliferative and anticancer activities. We investigated the effects of 1 on tubulin and microtubules. Using both an isolated tubulin assay, and a combination of sedimentation and Western blotting, we demonstrated that 1 is a tubulin-destabilising agent. This result was confirmed by immunofluorescence and confocal microscopy, which showed that microtubules in MCF-7 breast cancer cells were depolymerised when treated with 1. We synthesised a number of analogues of 1 to explore structure-activity relationships. Compound 13 had the best cytotoxic profile of this series, …
The Synthesis And Applications Of [2.2]Paracyclophane Derivatives, Craig Hicks
The Synthesis And Applications Of [2.2]Paracyclophane Derivatives, Craig Hicks
Doctoral
This work concerns the preparation of novel [2.2]paracyclophane derivatives intended for use as asymmetric ligands and investigations into surface coatings prepared from [2.2]paracylophanes. This begins with a general introduction to enantioselective synthesis, followed by a review of relevant reported ligands based on the [2.2]paracyclophane framework and their applications. Next is described the preparation of novel ligands based on the [2.2]paracyclophane structure. Starting with the preparation of a range of mono and disubstituted [2.2]paracyclophanes, including several novel analogues, this moves on to investigating resolution procedures where a novel method for the preparation of enantiopure 4-bromo[2.2]paracyclophane is described. The coupling of prepared …